The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium.

In guinea pig ventricular cardiomyocytes, the R(-)-enantiomer of efonidipine concentration-dependently blocked T-type Ca2+ current with 85% inhibition at 1 microM. In contrast, R(-)-efonidipine (1 microM) had no effect on the L-type Ca2+ current and Ca2+ transient in cardiomyocytes and contractile force in papillary muscles. Thus, R(-)-efonidipine is a highly selective blocker of the T-type Ca2+ current in native myocardia.

[1]  H. Masumiya,et al.  Frequency-dependent blockade of T-type Ca2+ current by efonidipine in cardiomyocytes. , 2000, Life Science.

[2]  H. Masumiya,et al.  Effects of Ca2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine. , 1997, European journal of pharmacology.

[3]  R. Yamagishi,et al.  Effect of cilnidipine on L- and T-type calcium currents in guinea pig ventricle and action potential in rabbit sinoatrial node. , 2004, Journal of Pharmacological Sciences.

[4]  Hikaru Tanaka,et al.  Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels. , 2006, Cardiovascular drug reviews.

[5]  E. Perez-Reyes.  Molecular physiology of low-voltage-activated t-type calcium channels. , 2003, Physiological reviews.

[6]  Y. Masuda,et al.  Efonidipine Hydrochloride: A New Calcium Antagonist , 1994 .

[7]  S. Ertel,et al.  Low-voltage-activated T-type Ca2+ channels. , 1997, Trends in pharmacological sciences.

[8]  H. Masumiya,et al.  Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect. , 1998, European journal of pharmacology.

[9]  T. Kawanishi,et al.  Restricted propagation of cytoplasmic Ca2+ oscillation into the nucleus in guinea pig cardiac myocytes as revealed by rapid scanning confocal microscopy and indo-1. , 1996, Japanese journal of pharmacology.

[10]  Y. Mori,et al.  Identification of R(−)‐isomer of efonidipine as a selective blocker of T‐type Ca2+ channels , 2004, British journal of pharmacology.